Page 1311 - Hall et al (2015) Principles of Critical Care-McGraw-Hill

2 References

27. Wheeler AP, Rice TW. Coagulopathy in critically ill patients: 42. Nayak MK, Kulkarni PP, Dash D. Regulatory role of proteasome
part 2-soluble clotting factors and hemostatic testing. Chest. in determination of platelet life span. J Biol Chem. March 8,
January 2010;137(1):185-194. 2013;288(10):6826-6834.
28. Orfeo T, Butenas S, Brummel-Ziedins KE, Mann KG. The 43. Rice TW, Wheeler AP. Coagulopathy in critically ill patients:
tissue factor requirement in blood coagulation. J Biol Chem. part 1: platelet disorders. Chest. December 2009;136(6):
December 30 2005;280(52):42887-42896. 1622-1630.
29. Levi M. Keep in contact: the role of the contact system in 44. Williamson DR, Albert M, Heels-Ansdell D, et al.
infection and sepsis. Crit Care Med. November 2000;28(11): Thrombocytopenia in critically ill patients receiving throm-
3765-3766. boprophylaxis: frequency, risk factors, and outcomes. Chest.
30. Sriskandan S, Kemball-Cook G, Moyes D, Canvin J, Tuddenham October 2013;144(4):1207-1215.
E, Cohen J. Contact activation in shock caused by invasive 45. Hui P, Cook DJ, Lim W, Fraser GA, Arnold DM. The fre-
group A Streptococcus pyogenes. Crit Care Med. November quency and clinical significance of thrombocytopenia com-
2000;28(11):3684-3691. plicating critical illness: a systematic review. Chest. February
31. Jansen PM, Pixley RA, Brouwer M, et al. Inhibition of factor XII 2011;139(2):271-278.
in septic baboons attenuates the activation of complement and 46. Crowther MA, Cook DJ, Meade MO, et al. Thrombocytopenia
fibrinolytic systems and reduces the release of interleukin-6 and in medical-surgical critically ill patients: prevalence, incidence,
neutrophil elastase. Blood. March 15, 1996;87(6):2337-2344. and risk factors. J Crit Care. December 2005;20(4):348-353.
32. Kim SY, Kim JE, Kim HK, Kim I, Yoon SS, Park S. Higher 47. Strauss R, Wehler M, Mehler K, Kreutzer D, Koebnick C, Hahn
prognostic value of soluble fibrin complexes than D-dimer EG. Thrombocytopenia in patients in the medical intensive
and fibrin degradation product for disseminated intravascu- care unit: bleeding prevalence, transfusion requirements, and
lar coagulation in patients with liver cirrhosis. Blood Coagul outcome. Crit Care Med. August 2002;30(8):1765-1771.
Fibrinolysis. March 2013;24(2):150-156. 48. Moreau D, Timsit JF, Vesin A, et al. Platelet count decline: an
33. Cioni G, Cristani A, Tincani E, Ventura P, Zagni G, early prognostic marker in critically ill patients with prolonged
Ventura E. Time sequence of coagulation data in patients with ICU stays. Chest. June 2007;131(6):1735-1741.
decompensated liver cirrhosis and suspected disseminated 49. Thiolliere F, Serre-Sapin AF, Reignier J, et al. Epidemiology and
intravascular coagulation. Ric Clin Lab. January-March 1991; outcome of thrombocytopenic patients in the intensive care
21(1):105-109. unit: results of a prospective multicenter study. Intensive Care
34. Bolliger D, Seeberger MD, Tanaka KA. Principles and practice Med. August 2013;39(8):1460-1468.
of thromboelastography in clinical coagulation management 50. Nijsten MW, ten Duis HJ, Zijlstra JG, et al. Blunted rise in
and transfusion practice. Transfus Med Rev. January 2012; platelet count in critically ill patients is associated with worse
26(1):1-13. outcome. Crit Care Med. December 2000;28(12):3843-3846.
35. Venema LF, Post WJ, Hendriks HG, Huet RC, de Wolf JT, de 51. Akca S, Haji-Michael P, de Mendonca A, Suter P, Levi M,
Vries AJ. An assessment of clinical interchangeability of TEG Vincent JL. Time course of platelet counts in critically ill
and RoTEM thromboelastographic variables in cardiac surgical patients. Crit Care Med. April 2002;30(4):753-756.
patients. Anesth Analg. August 2010;111(2):339-344.
36. Westbrook AJ, Olsen J, Bailey M, Bates J, Scully M, Salamonsen 52. Berkman N, Michaeli Y, Or R, Eldor A. EDTA-dependent
RF. Protocol based on thromboelastograph (TEG) out-performs pseudothrombocytopenia: a clinical study of 18 patients
physician preference using laboratory coagulation tests to guide and a review of the literature. Am J Hematol. March 1991;
blood replacement during and after cardiac surgery: a pilot 36(3):195-201.
study. Heart Lung Circ. August 2009;18(4):277-288. 53. Ibrahim R, Khan A, Raza S, et al. Triad of iron deficiency
37. Johansson PI, Stensballe J, Vindelov N, Perner A, Espersen anemia, severe thrombocytopenia and menorrhagia—a case
K. Hypocoagulability, as evaluated by thrombelastography, at report and literature review. Clin Med Insights Case Rep. 2012;
admission to the ICU is associated with increased 30-day mor- 5:23-27.
tality. Blood CoagulFibrinolysis. March 2010;21(2):168-174. 54. Koruk M, Onuk MD, Akcay F, Savas MC. Serum throm-
38. Adamzik M, Langemeier T, Frey UH, et al. Comparison of bopoietin levels in patients with chronic hepatitis and liver
thrombelastometry with simplified acute physiology score II cirrhosis, and its relationship with circulating thrombo-
and sequential organ failure assessment scores for the predic- cyte counts. Hepatogastroenterology. November-December
tion of 30-day survival: a cohort study. Shock. April 2011;35(4): 2002;49(48):1645-1648.
339-342. 55. Clark DA, Krantz SB. Effects of ethanol on cultured human
39. Ostrowski SR, Windelov NA, Ibsen M, Haase N, Perner A, megakaryocytic progenitors. Exp Hematol. November
Johansson PI. Consecutive thrombelastography clot strength 1986;14(10):951-954.
profiles in patients with severe sepsis and their association 56. Arnold DM, Nazi I, Warkentin TE, et al. Approach to the diag-
with 28-day mortality: a prospective study. J Crit Care. June nosis and management of drug-induced immune thrombocyto-
2013;28(3):317. e311-311. penia. Transfus Med Rev. July 2013;27(3):137-145.
40. Daudel F, Kessler U, Folly H, Lienert JS, Takala J, Jakob SM. 57. George JN, Raskob GE, Shah SR, et al. Drug-induced thrombo-
Thromboelastometry for the assessment of coagulation abnor- cytopenia: a systematic review of published case reports. Ann
malities in early and established adult sepsis: a prospective Intern Med. December 1, 1998;129(11):886-890.
cohort study. Crit Care. 2009;13(2):R42. 58. Arnold DM, Kukaswadia S, Nazi I, et al. A systematic evaluation
41. Harker LA. The kinetics of platelet production and destruction of laboratory testing for drug-induced immune thrombocyto-
in man. Clin Haematol. October 1977;6(3):671-693. penia. J Thromb Haemost. January 2013;11(1):169-176.

Section07-O-ref.indd 2 1/21/2015 11:26:47 AM